LIVANOVA PLC (LIVN) Stock News

NASDAQ:LIVN appears to be flying under the radar despite its strong fundamentals.

Discover LIVANOVA PLC, an undervalued stock. NASDAQ:LIVN showcases solid financial health and profitability while maintaining an appealing valuation.

LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance

Earnings Scheduled For February 25, 2025

Mentions: OUT HURN DNUT SRE ...

LivaNova to Present at the Barclays Global Healthcare Conference

LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results

LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer

RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression

LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting

LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences

LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints

LivaNova Reports Third-Quarter 2024 Results

LivaNova Appoints Susan Podlogar as a New Director

LivaNova's New Strategy Could Unlock Revenue, Profit Gains, Analyst Predicts

LivaNova gets Buy rating from Goldman Sachs analyst. $65 PT. The company appears poised for consistent revenue growth in its base business.

Mentions: GS

LivaNova to Announce Third-Quarter 2024 Results

LivaNova to Present at the Baird Global Healthcare Conference

LIVN Stock Earnings: LivaNova Beats EPS, Beats Revenue for Q2 2024

LIVN stock results show that LivaNova beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

LivaNova Reports Second-Quarter 2024 Results

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LivaNova PLC ("LivaNova" or the "Company") (NASDAQ: LIVN). Such investors are...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LivaNova PLC ("LivaNova" or the "Company") (NASDAQ: LIVN). Such investors are...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LivaNova PLC ("LivaNova" or the "Company") (NASDAQ: LIVN). Such investors are...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LivaNova PLC ("LivaNova" or the "Company") (NASDAQ: LIVN). Such investors are...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LivaNova PLC ("LivaNova" or the "Company") (NASDAQ: LIVN). Such investors are...

LivaNova to Announce Second-Quarter 2024 Results

LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients

LivaNova to Present at the Goldman Sachs Healthcare Conference

LIVN Stock Earnings: LivaNova Beats EPS, Beats Revenue for Q1 2024

LIVN stock results show that LivaNova beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

LivaNova Reports First-Quarter 2024 Results

LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer